Managing the PIP in Drug Development July 9, 2012

This masterclass will address the problems encountered during the creation of a PIP, as well as examining ways to overcome common challenges faced. The event will focus on the effects of a Paediatric Investigation Plan on the drug development landscape as a whole and will provide an in-depth overview into all perspectives of the PIP.

Attendees will be presented with current decisions from the EU Court of Justice and will have the opportunity to discuss PIP templates and documentation from the EMA website with an expert in the field, as well as considering current operational challenges when developing a PIP and finding solutions to overcome them.

Why you should attend:

* Analyse current EMA templates and documentation
* Evaluate all perspectives of PIPs in drug development
* Learn about novel decisions being made by the EU Court of Justice
* Discover ways to improve your current approach and increase success
* Debate with experts in the field, how best to overcome challenges in PIP development
* Network with key industry executives in the field of paediatrics

For further information about this event, visit http://www.smi-online.co.uk/paediatricplans5.asp

Alternatively, contact Vinh Trinh on +44 (0) 20 7827 6140 or email [email protected]

Official Website: http://www.smi-online.co.uk/paediatricplans5.asp